SNPHYOTCHealthcare · Drug Manufacturers - General

Santen Pharmaceutical Co., Ltd.

$11.88-0.92%($-0.11)

TickerSpark Score

86/100

Strong

Valuation

Profitability

Growth

Health

100

Momentum

Built from real-time financials and updated daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a SNPHY research report →

52-Week Range77% of range

Low $9.22

Current $11.88

High $12.68

Companywww.santen.com

Santen Pharmaceutical Co. , Ltd. researches and develops, manufactures, and markets pharmaceuticals and medical devices in Japan and internationally.

CEO: Takeshi Ito
IPO: 2011
Employees: 3,744
HQ: Osaka, JP

Price Chart

+13.25% · this period

Valuation

Market Cap: $3.82B
P/E: 16.38
P/S: 2.08
P/B: 2.06
EV/EBITDA: 8.26
Div Yield: 2.02%

Profitability

Gross Margin: 55.20%
Op Margin: 15.50%
Net Margin: 12.81%
ROE: 13.15%
ROIC: 10.68%

Growth & Income

Revenue: $309.21B · 3.07%
Net Income: $39.62B · 9.29%
EPS: $121.43 · 16.78%
Op Income: $47.94B
FCF YoY: -28.38%

Performance & Tape

52W High: $12.68
52W Low: $9.22
50D MA: $10.99
200D MA: $10.73
Beta: 0.23
Avg Volume: 12.54K

Get TickerSpark's AI analysis on SNPHY

Pro members can request AI-generated analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.

Get Pro Access →

30-day money-back guarantee · cancel anytime